Divis Laboratories Ltd | DIVI - Creditori Commerciali

Prezzo Delle Azioni
6,681.00
Cambio Giornaliero
30.00 0.45%
Mensile
14.21%
Annuale
8.67%
Q2 Previsione
6,358.14




Creditori Commerciali Cambiamento Data
Alaunos Therapeutics USD 613K 230K 2025-12
Aurobindo Pharma INR 47.51B 5.62B 2025-09
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.64B 112M 2026-03
Lupin INR 34.07B 4.49B 2025-09
Moderna USD 161M 156M 2026-03
Organon & Co USD 983M 31M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Tectonic Therapeutic USD 1.09M 392K 2025-12
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12